# This Changes Everything for Investors | Eliaz Therapeutics

- Canonical URL: https://wefunder.com/feed/184278
- Entity ID: wefunder:feed_item:184278
- Published at: 2025-07-31 20:07:07 UTC
- Updated at: 2025-08-03 12:26:00 UTC

## Author
Dr. Isaac Eliaz (MD)

## Subject
Eliaz Therapeutics

## Content
To our valued Wefunder community,I’ve had a couple of weeks now to reflect on my trip to the 15th ISFA World Congress in Bangkok, and I’m still feeling the energy from the event. The theme was “Apheresis for Tomorrow,” and being there truly felt like we were stepping directly into that future.Over the course of countless conversations with many of the world’s leading minds in apheresis, I witnessed an undeniable sense of urgency to move beyond older, less selective methods. What became profoundly clear is that the entire field, led by its most respected innovators, is shifting toward highly specific, targeted therapies. This is no longer a quote-unquote fringe idea, but rather, one that’s finally being embraced by medical communities across the globe. As an investor in Eliaz Therapeutics, this is the ultimate validation. YOU are entering a $62 billion market just as the solution it needs is being validated by the world’s bestYOU are backing an FDA Designated Breakthrough Device, XGal-3®YOU are part of a world-class team on a mission to save millions of lives. Together, we are creating a new standard of care. Yours in health,Isaac Eliaz, MD, MS, LAc